Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Month: July 2018

depression / psilocybin / research / treatment / unmet need

COMPASS Pathways – Access to Synthetic Psilocybin

COMPASS Pathways Targeting “Patient Access” to Synthetic Psilocybin COMPASS Pathways is a life sciences company, founded in 2016, to “accelerate patient access to evidence-based innovation in mental health.” According to their …

Recent Posts

  • CNN Reporting on Psilocybin and Magic Mushooms
  • Tim Ferriss and Psychedelics
  • No Magic Mushroom Monopoly
  • Three Key Points for Journalists Reporting on “Magic Mushrooms” or Psilocybin
  • DEA Puts Anti-Epileptic CBD Drug on Schedule V

Recent Comments

  • Tim Hagney on Tim Ferriss and Psychedelics
  • Eric Miller on Three Key Points for Journalists Reporting on “Magic Mushrooms” or Psilocybin
  • flowerpower on Cost of Psilocybin
  • Baja on Three Key Points for Journalists Reporting on “Magic Mushrooms” or Psilocybin
  • JoJo Wats on Cost of Psilocybin

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • aeruginascin
  • anxiety
  • business
  • cognitive enhancement
  • decriminalization
  • depression
  • law
  • legalization
  • mass
  • micro dosing
  • molecules vs. mushrooms
  • mushrooms
  • psilocin
  • psilocybin
  • psilocybin chemistry
  • psilocybin derivatives
  • Psilocybin Science
  • Psychedelic Science Review
  • research
  • state of the art
  • treatment
  • Uncategorized
  • unmet need
  • wood lover paralysis

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org
Copyright © 2019 Psilocybin Technology – OnePress theme by FameThemes